Menu
Recruiting NCT06675240

Meditative Neurofeedback for Depression

No phase Interventional Depression - Major Depressive Disorder Depression Disorders

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: MediNF.
Who it may be relevant to
Registry conditions: Depression - Major Depressive Disorder, Depression Disorders. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

The goal of this open-label single-arm study is to test a meditative neurofeedback intervention for depressed mood.

Detailed description

The goal of this open-label single-arm study is to test whether a 10-session meditative neurofeedback intervention significantly alleviates depressive symptons as well as improves secondary outcomes of rumination and mindfulness.

Interventions

  • Behavioral MediNF
    Over 10-sessions participants will engage in a breath-focused meditative practice with frontal brain connectivity neurofeedback provided to enhance performance.

Primary outcome measures

  • PHQ9 [Time frame: 8 weeks]
Secondary outcome measures (3)
  • MAAS [Time frame: 8 weeks]
  • RRQ [Time frame: 8 weeks]
  • GAD7 [Time frame: 8 weeks]

Eligibility criteria

Inclusion criteria

  • moderate depression per PHQ9 symptom ratings

Exclusion criteria

  • active substance abuse/dependence
  • psychotic disorders
  • bipolar disorder
  • displaying acutely suicidal behaviors

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

United States · 1 center
  • University of California San Diego — La Jolla

Identifiers

NCT: NCT06675240 · MediNF

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗